Browsing by Author Yung, MH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 20 of 31  next >
TitleAuthor(s)Issue Date
 
Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade
Journal:BMC Cancer
Yung, MHChan, DWLiu, VWSYao, KMNgan, HYS
2013
 
AMP-activated protein kinase gamma-2 (AMPK-g2) subunit modulates AMPK activities to ensure ovarian cancer progression
Proceeding/Conference:International Symposium on AMP-activated Protein Kinase, AMPK 2016
Chan, DWYung, MHHardie, DGNgan, HYS
2016
 
AMPK Activators Suppress Cervical Cancer Cell Growth through Inhibition of DVL3 Mediated Wnt/β-Catenin Signaling Activity
Journal:PLoS ONE
Kwan, HTChan, DWCai, CMak, SLYung, MHLeung, THYWong, GWCheung, ANYNgan, HYS
2013
 
The AMPK/TAK1 signaling axis is indispensable for controlling ovarian cancer cell metabolism and omental metastasis
Proceeding/Conference:CSHAsia 2013 Conference on Metabolism, Obesity & Obesity-associated Diseases
Chan, DWCai, CYung, MHNgan, HYS
2013
 
Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance
Journal:Oncogene
Zhou, WSun, WYung, MHDai, SCai, YChen, CWMeng, YLee, JBBraisted, JCXu, YSouthall, NTShinn, PHuang, XSong, ZChen, XKai, YCai, XLi, ZHao, QCheung, ANYNgan, HYSLiu, SBarak, SHao, JDai, ZTzatsos, APeng, WPei, HHan, ZChan, DWZheng, WZhu, W
2018
 
BCL2A1 plays a biphasic role in ovarian cancer progression: promoting cell survival and inhibiting cell proliferation
Proceeding/Conference:CSHAsia 2016 Conference on Cancer & Metabolism
Liang, RYung, MHNgan, HYSChan, DW
2016
 
Bitter melon (Momordica charantia) extract functions as a natural AMPK activator and synergistically enhances cisplatin cytotoxicity in ovarian cancer cells
Journal:Integrative Cancer Therapies
YUNG, MHROSS, FAHARDIE, DGZHAN, JBNgan, HYSChan, DW
2016
 
Bitter melon (Momordica charantia) extract inhibits tumorigenicity and overcomes cisplatin-resistance in ovarian cancer cells through targeting AMPK signaling cascade
Proceeding/Conference:HKU O & G 90th Anniversary Celebration-Symposium
Yung, MHLeung, THYNgan, HYSChan, DW
2015
 
Bitter melon extract (BME) used as natural AMPK activator in inhibiting ovarian cancer cells growth
Proceeding/Conference:CSH Asia / ICMS 2012 Joint Conference on Tumor Microenvironment
Yung, MHChan, DWNgan, HYS
2012
 
Bitter Melon Extract (BME) used as natural AMPK activator in inhibiting ovarian cancer cells growth
Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2012
Yung, MHChan, DWNgan, HYS
2012
 
Bitter Melon Extract (BME) used as natural AMPK activator in inhibiting ovarian cancer cells growth
Proceeding/Conference:Research Postgraduate Symposium, RPS 2012
Yung, MHChan, DWNgan, HYS
2012
 
DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling
Journal:Oncogene
Chan, DWHui, WWWang, JJYung, MHHui, MNQin, YIMINGLIANG, RLeung, THYXu, DChan, KKLYao, KMTsang, BKNgan, HYS
2016
 
DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer
Journal:Cancer Letters
Meng, YChen, CWYung, MHSun, WSun, JLi, ZLi, JLi, ZZhou, WLiu, SCheung, ANYNgan, HYSBraisted, JCKai, YPeng, WTzatsos, ALi, YDai, ZZheng, WChan, DWZhu, W
2018
 
Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB Axis
Journal:Cancers
WANG, XYung, MHSharma, RChen, FPoon, YTLam, WYLi, BNgan, HYSChan, KKLChan, DW
2021
 
ERK regulates HIF1α-mediated platinum resistance by directly targeting PHD2 in ovarian cancer
Journal:Clinical Cancer Research
Li, ZZhou, WZhang, YSun, WYung, MHSun, JLi, JChen, CWLi, ZMeng, YChai, JZhou, YLiu, SCheung, ANYNgan, HYSChan, DWZheng, WZhu, W
2019
 
Functional characterization of MAP30 protein from bitter melon (Momordica charantia) in combating ovarian cancer oncogenesis and chemoresistance
Proceeding/Conference:International Symposium on AMP-activated Protein Kinase, AMPK 2016
Yung, MHNgan, HYSHardie, DGChan, DW
2016
 
GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade
Proceeding/Conference:Cold Spring Harbour Asia Conference on Inflammation: Basic Mechanisms & Relevant Diseases
Chan, DWChen, RYung, MHNgan, HYS
2017
 
GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade
Journal:Theranostics
Yung, MHTang, WMCai, CHLeung, THYNgu, SFChan, KKLXu, DYang, HNgan, HYSChan, DW
2018
 
Identification of MAP30 as a natural AMPK activator in targeting the tumorigenicity and chemoresistance of ovarian cancer cells
Proceeding/Conference:CSHAsia 2016 Conference on Cancer & Metabolism
Yung, MHNgan, HYSChan, DW
2016
 
MAP30 protein of momordica charantia functions as a natural AMPK activator in combating tumorigenic and chemoresistant capacities of ovarian cancer
Proceeding/Conference:Croucher ASI 2013 on Tumour Microenvironment - Cancer Cell Metabolism
Chan, DWYung, MHNgan, HYS
2013
Showing results 1 to 20 of 31  next >